Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
R&D Milestone: HebaBiz Biotech's application for phase III clinical trial in China for Clevudine (L-FMAU), an anti-hepatitis B virus drug candidate under development has been approved 2021-11-15 22:47
Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373 2021-11-15 22:39
CARsgen Announces CAR T-cell Product Candidate CT041 Granted PRIME Eligibility by the EMA 2021-11-15 22:10
Senhwa Biosciences Announces Abstract Accepted for Presentation at the 2022 ASCO Gastrointestinal Cancers Symposium 2021-11-15 20:00
Qilian International Holding Group Limited Announces Initiation of Development of New Drug for Gastric Cancer Prevention 2021-11-15 20:00
RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients 2021-11-15 20:00
Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing 2021-11-15 19:00
Vazyme goes public on Shanghai Stock Exchange today 2021-11-15 16:28
Labcorp Opens New Integrated Laboratory, Strengthens Bioanalytical Services In Asia-Pacific 2021-11-15 16:00
Qiming's Portfolio Company Aohua Endoscopy Lands on STAR Market 2021-11-15 15:06
CBC Group Partners with APG to Launch Healthcare Real Estate Platform and Announce US$500 Million First Close of China Life Science Venture 2021-11-15 10:08
InnoCare Announces the Clearance of Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 by U.S. FDA 2021-11-15 08:30
Wision A.I. Achieves CE-MDR Mark Approval for AI-assisted Diagnostic Software Medical Device Supporting Colonoscopy 2021-11-15 08:30
Gannex Announces China NMPA Approved Phase II and III Protocols of ASC42, an FXR Agonist, for Treatment of Primary Biliary Cholangitis 2021-11-15 08:30
Antengene Presents Compelling Preclinical Data on Two Programs at the Society for Immunotherapy of Cancer (SITC) Annual Meeting on November 12, 2021 2021-11-15 08:25
Innovent Announces the Results of the Phase Ib Clinical Trial of IBI302, a First-in-class Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2021 American Academy of Ophthalmology 2021-11-15 08:00
$5M Boost to Innovation in Australia with New Illumina Genomics Lab 2021-11-15 06:14
Ascensia Diabetes Care Announce Winner of This is Diabetes Art and Photo Competition 2021-11-14 15:00
China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results 2021-11-13 05:30
Treadwell Therapeutics Announces A Presentation at the 2021 SITC Annual Meeting Featuring a Clinical Trial Update on CFI-402411, a First-in-Class HPK1 inhibitor 2021-11-13 02:56
1 321 322 323 324 325 894